See Centers for Disease Control and Prevention, supra note 1.
3.
45 CFR § 46 (2018).
4.
45 CFR § 46 (2018).
5.
21 U.S.C. § 301–399h (2019).
6.
21 CFR § 50.55 (2019).
7.
21 CFR § 50.3 (o) (2019).
8.
L.J.Bauman, C.A.Mellins, and R.Klitzman, “Whether to Waive Parental Permission in HIV Prevention Research Among Adolescents: Ethical and Legal Considerations,”Journal of Law, Medicine & Ethics48, no. 1 (2020): 188-201.
9.
Q.L.Moore, M.E.Paul, A.L.Mcguire, and M.A.Majumder, “Legal Barriers to Adolescent Participation in Research About HIV and Other Sexually Transmitted Infections,”American Journal of Public Health106, no. 1 (2016): 40–44.
See Centers for Disease Control and Prevention, supra note 11.
14.
See Moore, supra note 9.
15.
A.L.Gilbert, A.S.Knopf, J. D.Fortenberry, S.G.Hosek, B.G.Kapogiannis, and G. D.Zimet, “Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research,”Journal of Adolescent Health57, no. 1 (2015): 113–119.